Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases

TechCrunch | 5/30/2019 | Staff
Click For Photo: https://techcrunch.com/wp-content/uploads/2019/03/brainkey.png?w=764

For the past nineteen years, Ioannis Tarnanas, the founder and chief scientific officer at Altoida, has been developing virtual and augmented reality tools to offer predictions about the onset of mental illness in older patients.

The company, whose tools have been approved by the Food and Drug Administration for predicting Alzheimer’s, claims that it can determine whether someone will present with the disease six-to-ten years before the onset of mild cognitive impairment symptoms with a 94% accuracy.

Alzheimer - Dementias - US - Figure - Altoida

In 2019, Alzheimer’s and other dementias will cost the U.S. nearly $290 billion and that figure could rise as high as $1.1 trillion by 2050, according to Altoida.

The number of people living with Alzheimer’s disease is rapidly growing. In 2019 alone, Alzheimer’s disease and other dementias will cost the nation $290 billion. By 2050, these costs could rise as high as $1.1 trillion, but Altoida says that these costs can be prevented if the disease is caught early enough.

Altoida - IPad - Tablet - Accelerometer - Gyroscope

Altoida uses an iPad or a tablet accelerometer, a gyroscope, and touch screen sensors to detect what the company calls “micro-errors” as patients complete a series of AR and VR challenges. It’s basically a game of hide-and-seek where patients put virtual objects in different physical spaces in a clinical environment and then try to collect them.

Right now, the company’s technology is only available as a clinically supervised test in a doctor’s office, but the company is beginning to look at bringing its diagnostic tools into the home.

Field - Waves - Biomarkers - Biomarkers - Biomarkers

“In this field there are two major waves. Passive digital biomarkers and active digital biomarkers. With passive biomarkers you collect data from sensors,” says Tarnanas. “To give you an example of what this means in real life. [With passive digital biomarkers] you wind up collecting huge amounts of data and you see spikes and associate that with more everyday function or...
(Excerpt) Read more at: TechCrunch
Wake Up To Breaking News!
With God all things are possible, but not probable.
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!